This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Willis Towers Watson (WTW) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Stay Invested in Willis Towers (WTW)
by Zacks Equity Research
Segmental strength, solid capital position and favorable growth estimates make Willis Towers (WTW) stock worth retaining in one's portfolio.
Willis Towers Watson (WTW) Down 1.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Willis Towers Watson (WTW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Willis Towers (WLTW) Q4 Earnings Top Estimates, Revenues Lag
by Zacks Equity Research
Willis Towers (WLTW) Q4 results reflect solid performance of the Human Capital and Benefits (HCB) segment, Investment, Risk & Reinsurance, and Benefits Delivery & Administration, which was offset by softness in Corporate Risk & Broking.
Willis Towers Watson (WTW) Q4 Earnings Beat Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 5.98% and 3.35%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks Q4 Earnings on Feb 8: AIZ, WTW and More
by Tanuka De
Better pricing, exposure growth, solid retention, favorable renewals, reinsurance agreements, and accelerated digitalization likely have favored fourth-quarter results of AIZ, WTW, CNO and VOYA.
Will Willis Towers (WTW) Retain Its Beat Streak in Q4 Earnings?
by Zacks Equity Research
Willis Towers (WLTW) fourth-quarter results are likely to reflect the impact of growth in Medicare Advantage and Life sales, strong renewals and new business activity.
What's in the Cards for CME Group (CME) in Q4 Earnings?
by Zacks Equity Research
CME Group's (CME) fourth-quarter performance is likely to have been aided increased trading activity and lower costs.
Why Willis Towers Watson (WTW) Might Surprise This Earnings Season
by Zacks Equity Research
Willis Towers Watson (WTW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Willis Towers Watson (WTW) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Willis Towers Watson (WTW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arthur J. Gallagher (AJG) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Arthur J. Gallagher (AJG) delivered earnings and revenue surprises of 5.38% and 5.16%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
What Awaits Arthur J. Gallagher (AJG) This Earnings Season?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) fourth-quarter results are expected to reflect higher demand for consulting services, improvement in covered lives on renewal business and higher renewal exposure units.
Marsh & McLennan (MMC) Unit Unveils Digital Platform in Asia Pacific
by Zacks Equity Research
Marsh & McLennan (MMC) unit Oliver Wyman launches Edge for helping incumbent banks, tech firms and new entrants of the Asia Pacific region with enhanced digital capabilities.
Why Should You Add Marsh & McLennan (MMC) in Your Portfolio?
by Zacks Equity Research
Riding high on an enhanced portfolio and strategic initiatives, Marsh & McLennan (MMC) emerges as an attractive investment bet.
Here's Why Buying Brown and Brown (BRO) Stock Seems Prudent
by Zacks Equity Research
Improving new business, solid retention and continued rate increases for most lines of coverage should drive growth for Brown and Brown (BRO).
Marsh & McLennan (MMC) Arm Sells Associations Business to AMBA
by Zacks Equity Research
Marsh & McLennan (MMC) arm Mercer's divestment of Associations business is likely to close in the second quarter of this year.
This Week's Must-See Earnings Charts
by Tracey Ryniec
Which stocks will traders be watching this busy earnings week? These are some of those at the top of the list.
Weight Watchers (WTW) Surges: Stock Moves 5.4% Higher
by Zacks Equity Research
Weight Watchers (WTW) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Do Options Traders Know Something About Weight Watchers (WTW) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Weight Watchers (WTW) stock based on the movements in the options market lately.
Bull of the Day: Medifast (MED)
by David Borun
This innovative weight-loss company is producing better results than household name competitors with its innovative strategy
Weight Watchers (WTW) Surges: Stock Moves 8.5% Higher
by Zacks Equity Research
Weight Watchers (WTW) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Bear of the Day: Weight Watchers (WTW)
by Kevin Cook
Wall Street analysts didn't see this growth collapse coming and so buyers should beware
Weight Watchers International (WTW) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Weight Watchers International (WTW) closed the most recent trading day at $29.55, moving +1.62% from the previous trading session.
Weight Watchers (WTW) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Weight Watchers' (WTW) core Product Sales unit is expected to put up a soft show in fourth-quarter 2018.
Previewing Department Store Stock Earnings
by Sheraz Mian
The department store stocks enjoyed plenty of sunshine in 2018, but the mood shifted in a major way in November. While the rest of the market, including several other Retail sector industries, rebounded strongly after Christmas, the department store stocks never got a break.